Research presented at the recent annual meeting of the Academy of Managed Care Pharmacy highlights outcomes among patients ...

Adam Colborn, JD, associate vice president for congressional affairs, Academy of Managed Care Pharmacy, highlights key policy updates that are impacting managed care pharmacy.

Current observations and foresight into the world of biosimilars, GLP-1s, PBM and payer trends, according to Jeff Casberg, MS ...

The FDA has recently approved two new prophylactic treatments for people with hemophilia who develop antibodies to clotting factors.

In an interview with Adam Colborn, JD, director of government relations for the Academy of Managed Care Pharmacy focuses on biosimilar interchangeability and approaches to encourage wider adoption in ...

managed care, and community practice (Sidebar). This group meets with Magellan senior staff each quarter to discuss pharmacy policy and to provide recommendations for interpreting trends in drug use.

April 9 — Two University of Houston College of Pharmacy (UHCOP) researchers have been recognized with top honors from the Academy of Managed Care Pharmacy (AMCP) for their respective studies related ...

As managed care expands in the United States ... and the MCO may not fully calculate the total treatment spend for medical and pharmacy. Identifying how a new therapeutic may reduce overall ...

He has also published articles in the AMCP Managed Care Pharmacy Practice on Prescription Benefit Management and did speaking engagements on Specialty Drug Management, PBM 101 and Health Care ...

He used to skip blood pressure checks as he did not always have the time or money to visit the hospital or the pharmacy. I have hypertension ... increasing demand for health care, the City Council ...

as shown in 2 retrospective studies presented at the Academy of Managed Care Pharmacy annual meeting (AMCP 2025). The top 5 biosimilar conference articles in 2024 highlight significant progress in the ...